National Drug Strategy
National Drug Strategy

National Tobacco Strategy 2012-2018: Draft for consultation

5.4 Priority areas

prev pageTOC |next page

This draft Strategy identifies eight priority areas for future action. These priority areas have been informed by the extensive evidence base for tobacco control and reflect best practice approaches to reduce the harm caused by smoking. They contain demand reduction, supply reduction and harm reduction approaches and build on the progress we have made over the past four decades.

Experience in Australia and internationally shows that reducing smoking rates requires a comprehensive and sustained approach. Reflecting this comprehensive public health approach, the priority areas in this draft Strategy include actions to eliminate the remaining advertising, promotion and sponsorship of tobacco products, reduce the affordability of tobacco products, increase smoke free areas, strengthen social marketing campaigns and cessation services and consideration of further regulation of the contents of tobacco products, product disclosure and the supply of tobacco products.

This draft Strategy also has a strong commitment to reducing the social inequalities associated with tobacco use. It therefore includes a strong emphasis on working in partnership to reduce smoking rates among Aboriginal and Torres Strait Islander people and other disadvantaged groups.

The eight priority areas are:

  1. strengthen social marketing campaigns to discourage uptake of smoking; motivate smokers to quit; prevent relapse; and reshape social norms about smoking;
  2. continue to reduce the affordability of tobacco products;
  3. bolster and build on existing programs and partnerships to reduce smoking rates among Aboriginal and Torres Strait Islander people;
  4. strengthen efforts to reduce smoking among people in disadvantaged populations with high smoking prevalence;
  5. eliminate remaining advertising, promotion and sponsorship of tobacco products;
  6. consider further regulation of the contents, product disclosure and supply of tobacco products and non therapeutic nicotine delivery systems;
  7. reduce exceptions to smoke free workplaces, public places and other settings; and
  8. provide greater access to a range of evidence based cessation services to support smokers to quit.

    prev pageTOC |next page